How fermentation-derived ingredients reach the Australia and New Zealand market
Food Standards Australia New Zealand (FSANZ) does not run a notification system for new ingredients. A company that wants to sell a protein, sweetener, oligosaccharide or enzyme made by a genetically modified microorganism generally has to lodge an application to amend the Australia New Zealand Food Standards Code. Each application receives an A-number (for example A1342) and a public page on the FSANZ website, and its progress is documented in a series of reports. For anyone tracking precision fermentation in the region, those A-numbers are the most reliable trail of who is trying to enter the market, with which production strain, and how far they have got.
What counts as a fermentation-derived application
FSANZ files applications by regulatory category rather than by production technology, so fermentation-derived ingredients appear across several categories:
- Processing aids – enzymes such as cellulase, lipase, glucoamylase, transglutaminase or thermolysin produced by strains of Trichoderma reesei, Aspergillus niger, Bacillus species and others. This is the largest group; FSANZ's own application register files more than a hundred applications under the processing-aid category.
- Nutritive substances for infant formula – human-milk oligosaccharides (2′-FL, 3-FL, LNT, 3′-SL, 6′-SL) made by GM Escherichia coli or Corynebacterium glutamicum. Several applications cover a new production strain for a substance that is already permitted.
- Novel foods and GM ingredients – animal-free dairy proteins and other proteins expressed in yeasts such as Komagataella phaffii, as well as fungal biomass ingredients.
- Food additives – for example sweet proteins expressed in yeast and proposed as intense sweeteners, and steviol glycosides produced by fermentation or enzymatic conversion.
Reading an application file
The most information-dense document in each file is the Administrative Assessment Report, published when FSANZ accepts the application. It states the date received, the applicant, a brief description, the procedure and its level, the maximum variable hours FSANZ expects to spend, and the standards or schedules likely to be affected. The procedure level is a useful proxy for regulatory complexity:
| Example | Procedure | Max. variable hours |
|---|---|---|
| A1334 – new 2′-FL production strain | General Level 2 | 290 |
| A1359 – sweet protein as a food additive | General Level 3 | 420 |
| A1339 – five HMOs from GM E. coli BL21 | General Level 5 | 658 |
| A1342 – beta-casein protein preparation from GM yeast | General Level 5 | 668 |
After acceptance, a file typically moves through a call for submissions (with a risk and technical assessment published as a supporting document), an approval report and a decision by the FSANZ Board, followed by consideration by food ministers before the change is gazetted. For example, the Board approved A1334 on 10 March 2026, and A1339 and A1340 on 3 June 2026.
Why the production organism matters
Approval is tied to a specific source organism and, for GM strains, often to the gene donor as well. A competitor making the same molecule with a different strain usually needs its own application, which is why the register contains a run of 2′-FL applications from different producers and strains. The production organism and gene donor are therefore the fields that tell a regulatory team whether an existing permission can be relied on or whether a new dossier is needed.
Who uses this information
- Regulatory consultants benchmarking timelines and procedure levels before quoting a new dossier.
- Precision fermentation start-ups and investors checking which competitors have filed in Australia and New Zealand, and at what stage.
- Ingredient distributors and food manufacturers identifying suppliers whose ingredients are permitted or approaching approval in the region.